Atrás
Nationally ranked among the best cancer hospital in the US, our center treats a high volume of patients with many types of cancer, making it a destination center of excellence, especially for high-risk or complex cases.
Descubra por qué Baylor es su destino para la atención del cáncer
Quiere Baylor Scott & White Charles A. Sammons Cancer Center - Dallas, un centro de cáncer líder en el norte de Texas.
Our unmatched cancer programs across outpatient and inpatient care make us one of the best cancer treatment centers in Texas, offering quality, coordinated cancer care in Dallas across the patient journey.
Every cancer patient has a unique set of circumstances that require a personalized plan of care. The multidisciplinary team of top cancer physicians in Dallas on the centers’ medical staffs and the oncology-trained staff across our Cancer Research and Treatment Centers and other specialized programs take your cancer treatment approach to the next level. At Baylor Scott & White Charles A. Sammons Cancer Center – Dallas, developing an innovative treatment plan involves the collaboration of the patient’s primary care physician with physicians and experts across several relevant disciplines.
During multidisciplinary tumor board conferences, difficult-to-treat patient cases are reviewed, including type and stage of malignancy, medical history, and the patient’s age and personal preferences. Our team of leading Dallas cancer specialists thoroughly discuss and evaluate treatment options and offer recommendations regarding minimally invasive treatments, surgery, or advanced and innovative techniques, including immunotherapy where appropriate.
Nuestro programa de navegación para pacientes atiende a los pacientes desde el diagnóstico, durante el tratamiento y hasta la supervivencia. Su asesor de pacientes estará allí para ofrecer orientación a los pacientes y sus familias en cada paso del camino.
Contact a patient navigator by calling 214.820.3535.
As a major academic medical center with a multidisciplinary team of researchers and expert cancer physicians on its medical staff, Baylor University Medical Center can access the support of Baylor Scott & White Research Institute to administer effective therapies, manufacture immunotherapy treatment and conduct lab work where patients are being treated.
Como pionero en investigación y tratamiento en inmunoterapias, el Baylor University Medical Center fue el primer proveedor del norte de Texas en ofrecer el uso comercial para adultos de la terapia de células T con receptores de antígenos quiméricos, o CAR-T, para tratar a pacientes con linfoma de células B grandes y leucemia linfoblástica aguda.
El panorama de la atención del cáncer ha cambiado drásticamente en los últimos 10 años. Vea cómo Baylor Scott & White sigue siendo un líder en los avances en la investigación del cáncer.